carbamates has been researched along with Atherosclerotic Parkinsonism in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although levodopa improves PD symptoms in the initial stages of the disease, its long-term use is limited by the development of side effects, including abnormal involuntary movements (dyskinesias) and psychiatric complications." | 1.34 | Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. ( Cassano, T; Cuomo, V; Giuffrida, A; Morgese, MG, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgese, MG | 1 |
| Cassano, T | 1 |
| Cuomo, V | 1 |
| Giuffrida, A | 1 |
1 other study available for carbamates and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.
Topics: Amidohydrolases; Animals; Antiparkinson Agents; Arachidonic Acids; Basal Ganglia; Benzamides; Benzox | 2007 |